Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines.
Murphy
Brian R
BR
Respiratory Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-8007, USA. bmurphy@niaid.nih.gov
Coelingh
Kathleen
K
D000222:Adaptation, Physiological; D000818:Animals; D003080:Cold Temperature; D015195:Drug Design; D006801:Humans; D009980:Influenza A virus / Q000235:genetics / Q000276:immunology*; D009981:Influenza B virus / Q000235:genetics / Q000276:immunology*; D007252:Influenza Vaccines / Q000235:genetics / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control*; D014613:Vaccines, Attenuated
D007252:Influenza Vaccines; D014613:Vaccines, Attenuated